These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38854273)

  • 1. Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review.
    Manjhi PK; Singh MP; Kumar M
    Cureus; 2024 May; 16(5):e59975. PubMed ID: 38854273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India.
    Sharma A; Kumari KM; Manohar HD; Bairy KL; Thomas J
    Perspect Clin Res; 2015; 6(2):109-15. PubMed ID: 25878957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
    More SA; Atal S; Mishra PS
    J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of serious adverse drug reactions at a tertiary care teaching hospital.
    Prajapati K; Desai M; Shah S; Panchal J; Kapadia J; Dikshit R
    Perspect Clin Res; 2016; 7(4):181-186. PubMed ID: 27843794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder in Psychiatry Outpatient Department of a Tertiary Care Hospital.
    Shah A; Yadav PP; Chaudhari M; Vataliya A; Kantharia ND; Mehta R
    J Clin Diagn Res; 2017 May; 11(5):FC24-FC28. PubMed ID: 28658799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance Study of Anticancer Drugs in a Tertiary Care Teaching Hospital in North India: A Retrospective Study.
    Kumar R; Jindal A; Garg P; Kaur A; Kumar S; Tilak Raj R; Singh S
    Cureus; 2023 Sep; 15(9):e44984. PubMed ID: 37822427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in chhattisgarh: A retrospective analysis.
    Keche Y; Gaikwad N; Dhaneria S
    J Family Med Prim Care; 2021 Jul; 10(7):2541-2545. PubMed ID: 34568133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study.
    Surendiran A; Balamurugan N; Gunaseelan K; Akhtar S; Reddy KS; Adithan C
    Indian J Pharmacol; 2010 Feb; 42(1):40-3. PubMed ID: 20606836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reaction profile of oseltamivir in Indian population: A prospective observational study.
    Anovadiya AP; Barvaliya MJ; Shah RA; Ghori VM; Sanmukhani JJ; Patel TK; Tripathi CB
    Indian J Pharmacol; 2011 May; 43(3):258-61. PubMed ID: 21713087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Drug Reaction Profile of Anticancer Agents in a Tertiary Care Hospital: An Observational Study.
    Shaikh SP; Nerurkar R
    Curr Drug Saf; 2022; 17(2):136-142. PubMed ID: 34433404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability.
    Ithnin M; Mohd Rani MD; Abd Latif Z; Kani P; Syaiful A; Nor Aripin KN; Tengku Mohd TAM
    JMIR Mhealth Uhealth; 2017 May; 5(5):e78. PubMed ID: 28559222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
    Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
    Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study.
    Gupta SK; Kumar KD
    Int J Pharm Investig; 2017; 7(4):193-197. PubMed ID: 29692979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital.
    Amin S; Shah S; Desai M; Shah A; Maheriya KM
    Perspect Clin Res; 2018; 9(2):70-75. PubMed ID: 29862199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causality assessment of adverse drug reactions by applying a global introspection method in a high complexity hospital.
    Rezende de Menezes R; Graciano Silva MDD; Pinho Ribeiro AL; Martins Pinto Filho M; Martinho GH; Carvalho Ferreira LE; Parreiras Martins MA
    Explor Res Clin Soc Pharm; 2021 Sep; 3():100064. PubMed ID: 35480605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.